Ocuphire Pharma Engages Investors with Presentation Update
Company Announcements

Ocuphire Pharma Engages Investors with Presentation Update

Ocuphire Pharma (OCUP) just unveiled an announcement.

Ocuphire Pharma, Inc. is set to engage with investors and other interested parties by presenting their Investor Presentation. The information shared during these sessions, while informative, is not intended for official filing or legal incorporation purposes under the Securities Exchange Act of 1934 or the Securities Act of 1933.

Learn more about OCUP stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyTwo new option listings and one option delisting on October 24th
TheFlyOcuphire Pharma price target lowered to $10 from $18 at Canaccord
TheFlyOcuphire Pharma rating placed under review at H.C. Wainwright
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App